Abivax has appointed Michael Nesrallah as its chief commercial officer, putting one of the people who turned Takeda’s Entyvio into a blockbuster in charge of preparations for its own ulcerative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results